Clinical Trial Update: Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating moderated hypofractionated online adaptive radiotherapy for cervical cancer is currently recruiting. The sponsor is Peking U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cervical Cancer, Adaptive Radiotherapy | Phase 3 | Status: RECRUITING